Avalo Therapeutics Inc Revenue per Employee (AVTX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Avalo Therapeutics Inc   (NASDAQ: AVTX)
 

Avalo Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Avalo Therapeutics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 1,788, below the company average number of $366,734.
Within the Healthcare sector Avalo Therapeutics Inc achieved the highest revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. .Avalo Therapeutics Inc has 33 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AVTX Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change - - -69.27 % - -
Sales per Employee (TTM) $ 1,788 1,788 1,788 5,818 13,364
AVTX's Total Ranking # # # # #
Seq. Revenue Change - - - - -

AVTX Company Profile >> Back to AVTX Efficiency Comparisons >> Compare AVTX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 1,107,244 $ 366,734 $ -106,708
(Jun 30 2018)   (Sep 30 2020)



Financial Statements
Avalo Therapeutics Inc 's Revenue MRQ $ 0 Millions Visit AVTX's Income Statement
Avalo Therapeutics Inc 's Revenues TTM $ 0 Millions Visit AVTX's aggregate revenue growth
What are AVTX's Sales? Visit AVTX's Sales by Segment




Other Ratios
Avalo Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
AVTX's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for AVTX's Competitors
Revenue per Employee for AVTX's Suppliers
Revenue per Employee for AVTX's Customers

You may also want to know
AVTX's Sales Growth Rates AVTX's Pe Price to earnings ratio AVTX's Receivables Turnover Ratio AVTX's Stock Quote
AVTX's Net Income Growth Rates AVTX's Ps Price to Sales ratio AVTX's Sales per Employee AVTX's Asset Turnover Ratio
AVTX's Net Margin AVTX's Pb Price to Book ratio AVTX's Financial Strength Ratios AVTX's Dividend Payout Ratio
Date modified: 2026-09-06T17:49:33+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Pavmed Inc   3,073.17 $ 0.126  Million 41 
Clene Inc   2,493.67 $ 0.197  Million 79 
Aspire Biopharma Holdings Inc   2,281.51 $ 0.103  Million 45 
Sera Prognostics Inc   972.22 $ 0.070  Million 72 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.